Use of coenzyme Q10 formulations in the treatment and prevention of epidermolysis bullosa

摘要

The present invention is directed, in part, to methods of treating Epidermolysis Bullosa (EB) in a subject in need thereof, comprising topical administration of a pharmaceutical composition comprising a therapeutically effective amount of a of Coenzyme Q10 (CoQIO) to the subject.